Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,307
Closed -$432K 134
2022
Q1
$432K Hold
6,307
0.03% 128
2021
Q4
$499K Hold
6,307
0.03% 125
2021
Q3
$498K Hold
6,307
0.03% 117
2021
Q2
$497K Hold
6,307
0.03% 119
2021
Q1
$476K Hold
6,307
0.03% 116
2020
Q4
$415K Hold
6,307
0.03% 121
2020
Q3
$340K Hold
6,307
0.02% 115
2020
Q2
$303K Hold
6,307
0.02% 123
2020
Q1
$215K Hold
6,307
0.02% 124
2019
Q4
$395K Buy
+6,307
New +$357K 0.02% 135

Other funds holding ENOV

Oak Associates's ENOV Position: Q2 2022 in Review

Oak Associates sold out of Enovis (ENOV) in Q2 2022, closing a stake of 6,307 shares — an estimated $432K sold.

Oak Associates first reported a position in ENOV in Q4 2019 and held it in 10 quarters. The position peaked at $499K in Q4 2021. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.

  • Oak Associates reported no remaining Enovis position as of Q2 2022 after selling out during the quarter.
  • Oak Associates sold 6,307 Enovis shares in Q2 2022, an estimated $432K.
  • Oak Associates first reported a position in Enovis in Q4 2019 and held it in 10 quarters.
  • Oak Associates's Enovis position peaked at $499K in Q4 2021.
  • 245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.

Based on Oak Associates's 13F filing for Q2 2022, filed 12 Aug 2022.